Johnson Investment Counsel’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-872
| Closed | -$425K | – | 892 |
|
|
2025
Q4 | $425K | Hold |
872
| – | – | ﹤0.01% | 586 |
|
|
2025
Q3 | $366K | Hold |
872
| – | – | ﹤0.01% | 643 |
|
|
2025
Q2 | $251K | Sell |
872
-370
| -30% | -$111K | ﹤0.01% | 715 |
|
|
2025
Q1 | $383K | Sell |
1,242
-3
| -0.2% | -$1.03K | ﹤0.01% | 585 |
|
|
2024
Q4 | $439K | Hold |
1,245
| – | – | ﹤0.01% | 554 |
|
|
2024
Q3 | $446K | Sell |
1,245
-2
| -0.2% | -$676 | ﹤0.01% | 539 |
|
|
2024
Q2 | $397K | Sell |
1,247
-1
| -0.1% | -$265 | ﹤0.01% | 534 |
|
|
2024
Q1 | $287K | Sell |
1,248
-4
| -0.3% | -$903 | ﹤0.01% | 620 |
|
|
2023
Q4 | $275K | Buy |
+1,252
| New | +$289K | ﹤0.01% | 607 |
|
|
2018
Q4 | – | Sell |
-8,085
| Closed | -$1.03M | – | 648 |
|
|
2018
Q3 | $1.03M | Hold |
8,085
| – | – | 0.02% | 321 |
|
|
2018
Q2 | $914K | Buy |
8,085
+1,651
| +26% | +$181K | 0.02% | 322 |
|
|
2018
Q1 | $722K | Buy |
6,434
+1,134
| +21% | +$144K | 0.02% | 349 |
|
|
2017
Q4 | $784K | Sell |
5,300
-235
| -4% | -$29.9K | 0.02% | 328 |
|
|
2017
Q3 | $648K | Hold |
5,535
| – | – | 0.02% | 351 |
|
|
2017
Q2 | $718K | Buy |
5,535
+41
| +0.7% | +$5.12K | 0.02% | 313 |
|
|
2017
Q1 | $743K | Buy |
5,494
+194
| +4% | +$29.4K | 0.02% | 292 |
|
|
2016
Q4 | $760K | Hold |
5,300
| – | – | 0.02% | 277 |
|
|
2016
Q3 | $625K | Hold |
5,300
| – | – | 0.02% | 300 |
|
|
2016
Q2 | $561K | Hold |
5,300
| – | – | 0.02% | 318 |
|
|
2016
Q1 | $590K | Hold |
5,300
| – | – | 0.02% | 296 |
|
|
2015
Q4 | $830K | Sell |
5,300
-2,300
| -30% | -$335K | 0.03% | 245 |
|
|
2015
Q3 | $997K | Hold |
7,600
| – | – | 0.04% | 209 |
|
|
2015
Q2 | $1.32M | Hold |
7,600
| – | – | 0.04% | 193 |
|
|
2015
Q1 | $1.31M | Hold |
7,600
| – | – | 0.04% | 194 |
|
|
2014
Q4 | $984K | Hold |
7,600
| – | – | 0.03% | 222 |
|
|
2014
Q3 | $977K | Hold |
7,600
| – | – | 0.03% | 220 |
|
|
2014
Q2 | $672K | Hold |
7,600
| – | – | 0.02% | 237 |
|
|
2014
Q1 | $714K | Hold |
7,600
| – | – | 0.03% | 226 |
|
|
2013
Q4 | $859K | Hold |
7,600
| – | – | 0.03% | 208 |
|
|
2013
Q3 | $599K | Hold |
7,600
| – | – | 0.02% | 233 |
|
|
2013
Q2 | $500K | Buy |
+7,600
| New | +$490K | 0.02% | 250 |
|
Other funds holding UTHR
ACA
Johnson Investment Counsel's UTHR Position: Q1 2026 in Review
Johnson Investment Counsel sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 872 shares — an estimated $425K sold.
Johnson Investment Counsel first reported a position in UTHR in Q2 2013 and held it in 31 quarters. The position peaked at $1.32M in Q2 2015. 853 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Johnson Investment Counsel reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
- Johnson Investment Counsel sold 872 United Therapeutics shares in Q1 2026, an estimated $425K.
- Johnson Investment Counsel first reported a position in United Therapeutics in Q2 2013 and held it in 31 quarters.
- Johnson Investment Counsel's United Therapeutics position peaked at $1.32M in Q2 2015.
- 853 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Johnson Investment Counsel's 13F filing for Q1 2026, filed 4 May 2026.